期刊文献+

金黄色葡萄球菌耐药机制及治疗药物

Mechanism of Drug Resistance and Treatment of Staphylococcus aureus
下载PDF
导出
摘要 金黄色葡萄球菌(Staphylococcus aureus)是引起局部化脓和心内膜炎等多种感染的重要人兽共患革兰阳性病原菌。其传播速度快,致病力强,且耐药性日益严重,给全球公共卫生安全和动物养殖业造成了巨大威胁。这对深入了解金黄色葡萄球菌耐药机制以及药物新靶点的开发提出了迫切需求。因此,本文对当前临床使用的抗生素的作用机制和耐药机理进行了综述,并特别关注了相关领域的最新研究进展,以期望为临床防治细菌耐药和新药研制提供新的视角和参考。 Staphylococcus aureus(S.aureus)is a widespread Gram-positive zoonotic bacterial pathogen causing a variety of infections including septicemia and endocarditis.Due to its rapid spread,high pathogenicity and increasing drug resistance,S.aureus has become a serious threat to global public health and animal breeding.This has created an urgent need for an improved understanding of S.aureus mechanism-of-resistance and the discovery of drugs for potential targets.Therefore,this review summarized the mechanism-of-action and mechanism-of-resistance of anti-S.aureus in current clinical use,to provide new perspectives and references for the prevention and treatment of bacterial resistance and new drug development.
作者 罗丹 马世伟 王哲 Luo Dan;Ma Shi-wei;Wang Zhe(School of Agriculture and Biology,Shanghai Jiao tong university,Shanghai 200240;Shanghai Key Laboratory of Veterinary Biotechnology,Shanghai 200240)
出处 《国外医药(抗生素分册)》 CAS 2024年第1期1-11,共11页 World Notes on Antibiotics
基金 国家重点研发计划(2021YFD1800401)。
关键词 金黄色葡萄球菌 耐药机制 蛋白质合成抑制剂 核酸合成抑制剂 细胞壁合成抑制剂 Staphylococcus aureus resistance mechanism protein synthesis inhibitor nucleic acid synthesis inhibitor cell wall synthesis inhibitor
  • 相关文献

参考文献3

二级参考文献27

  • 1[1]Ubukata K, Itoh NY, Konno M, et al. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1989, 33(9): 1535
  • 2[2]Yoshida H, Bogaki M, Nakamura S, et al. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. [J]. J Bacteriol,1990, 172(12): 6942
  • 3[3]Kaatz GW, Seo SM, Ruble CA, et al. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. [J].Antimicrob Agents Chemother, 1993, 37(5): 1086
  • 4[4]Sierra JM, Ruiz J, Jimenez DMT, et al. Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus. [J]. J Antimicrob Chemother,2000, 46(1): 145
  • 5[5]Ng EYW, Trucksis M, Hooper DC. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. [J]. Antimicrob Agents Chemother, 1994, 38(6): 1345
  • 6[6]Fournier B, Aras R, Hooper DC. Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system.[J]. J Bacteriol, 2000, 182(3): 664
  • 7[7]Kaatz GW, Seo SM. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1995, 39(12): 2650
  • 8[8]Munoz-Bellido JL, Alonso MM, Martinez JA, et al. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA and norA.[J]. Antimicrob Agents Chemother, 1999, 43(2): 354
  • 9[9]Kaatz GW, Seo SM, Foster TJ. Intriduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid intergration. [J ]. Antimicrob Agents Chemother, 1999, 43(9): 2222
  • 10[10]Yamada H, Kurose-Hamada S, Fukuda Y, et al.Quinolone susceptibility of norA-disrupted Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1997,41(10): 2308

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部